These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12439600)

  • 1. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
    Mauceri HJ; Seetharam S; Beckett MA; Schumm LP; Koons A; Gupta VK; Park JO; Manan A; Lee JY; Montag AG; Kufe DW; Weichselbaum RR
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):412-8. PubMed ID: 12439600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
    Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
    Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin.
    Gorski DH; Mauceri HJ; Salloum RM; Gately S; Hellman S; Beckett MA; Sukhatme VP; Soff GA; Kufe DW; Weichselbaum RR
    Cancer Res; 1998 Dec; 58(24):5686-9. PubMed ID: 9865723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy.
    Gorski DH; Mauceri HJ; Salloum RM; Halpern A; Seetharam S; Weichselbaum RR
    Cancer Res; 2003 Jan; 63(2):308-11. PubMed ID: 12543780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic efficacy of angiostatin against weakly- and highly-immunogenic 3LL tumors.
    Li M; Huang X; Zhu Z; Zhao Q; Wong M; Gorelik E
    In Vivo; 2002; 16(6):577-82. PubMed ID: 12494903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth.
    O'Reilly MS
    EXS; 1997; 79():273-94. PubMed ID: 9002223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer.
    Sim BK; O'Reilly MS; Liang H; Fortier AH; He W; Madsen JW; Lapcevich R; Nacy CA
    Cancer Res; 1997 Apr; 57(7):1329-34. PubMed ID: 9102221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
    Kimura Y; Taniguchi M; Baba K
    Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: possible biochemical mechanism of angiostatin's action.
    Sharma MR; Rothman V; Tuszynski GP; Sharma MC
    Exp Mol Pathol; 2006 Oct; 81(2):136-45. PubMed ID: 16643891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin.
    Dings RP; Yokoyama Y; Ramakrishnan S; Griffioen AW; Mayo KH
    Cancer Res; 2003 Jan; 63(2):382-5. PubMed ID: 12543791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
    MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
    Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour and antimetastatic effect of genistein alone or combined with cyclophosphamide in mice transplanted with various tumours depends on the route of tumour transplantation.
    Wietrzyk J; Opolski A; Madej J; Radzikowski C
    In Vivo; 2000; 14(2):357-62. PubMed ID: 10836210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma.
    Murphy KT; Wardak A; Beckett MA; Lopez CA; Mehta N; Kimchi E; Salloum RM; Jaskowiak NT; Posner MC; Ohno T; Kufe DW; Weichselbaum RR; Mauceri HJ
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):317-21. PubMed ID: 15887016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.
    Datta A; Kitson RP; Xue Y; al-Atrash G; Mazar AP; Jones TR; Goldfarb RH
    In Vivo; 2002; 16(6):451-7. PubMed ID: 12494889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of angiostatin and ionizing radiation in antitumour therapy.
    Mauceri HJ; Hanna NN; Beckett MA; Gorski DH; Staba MJ; Stellato KA; Bigelow K; Heimann R; Gately S; Dhanabal M; Soff GA; Sukhatme VP; Kufe DW; Weichselbaum RR
    Nature; 1998 Jul; 394(6690):287-91. PubMed ID: 9685160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity.
    Salloum RM; Jaskowiak NT; Mauceri HJ; Seetharam S; Beckett MA; Koons AM; Hari DM; Gupta VK; Reimer C; Kalluri R; Posner MC; Hellman S; Kufe DW; Weichselbaum RR
    Cancer Res; 2000 Dec; 60(24):6958-63. PubMed ID: 11156396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term expression of angiostatin suppresses metastatic liver cancer in mice.
    Xu R; Sun X; Tse LY; Li H; Chan PC; Xu S; Xiao W; Kung HF; Krissansen GW; Fan ST
    Hepatology; 2003 Jun; 37(6):1451-60. PubMed ID: 12774025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model.
    te Velde EA; Vogten JM; Gebbink MF; van Gorp JM; Voest EE; Borel Rinkes IH
    Br J Surg; 2002 Oct; 89(10):1302-9. PubMed ID: 12296902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
    Shiraga E; Barichello JM; Ishida T; Kiwada H
    Int J Pharm; 2008 Apr; 353(1-2):65-73. PubMed ID: 18155369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitizer AK-2123 as modulating agent in the chemotherapy of experimental metastases.
    Konovalova NP; Diatchkovskaya RF; Volkova LM; Kagiya TV
    Neoplasma; 1995; 42(3):119-22. PubMed ID: 7637820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.